APACC 2016

Sensitive Detection of Tenofovir-induced Tubular Injury with Urinary ß-2 Microglobuline in Vietnam | Daisuke Mizushima

Slideset

HIV

Viral Hepatitis and Liver Disease

Tenofovir-induced kidney tubular dysfunction in HIV-infected patients in Hong Kong | Denise Chan

Slideset

HIV

Viral Hepatitis and Liver Disease

Using the HVTN model to conduct HIV vaccine clinical trials | Xia Jin, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Safety and efficacy of tenofovir disoproxil fumarate plus emtricitabine for HIV pre-exposure prophylaxis in Thailand | Donn Colby, MD, MPH

Slideset

HIV

Viral Hepatitis and Liver Disease

Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Towards an HIV Cure; understanding the major barriers | Sharon Lewin, AO, FRACP, PhD, FAHMS

Slideset

HIV

Viral Hepatitis and Liver Disease

Transmitted drug resistance mutations among antiretroviral-naÏve adult patients in northern Vietnam | Vu Phuong Thao, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

The impact of NRTI resistance on the public health approach to PI-based second-line therapy in resource limited settings | Thuy Le, MD, DPhil

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV Drug Resistance | Shinichi Oka, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Next Generation Sequencing for Detection of Drug Resistance Mutations in HIV-1 | Dr. Rakhmanaliev

Slideset

HIV

Viral Hepatitis and Liver Disease

They are not kids anymore: Standing at the crossroads of adolescent HIV Care | Annette Sohn, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Elimination of perinatal HIV: the Role of Safer Conception Strategies | Shannon Weber, MSW

Slideset

HIV

Viral Hepatitis and Liver Disease

Psychosocial Determinants of Anxiety and Depression among Children of HIV-infected Parents: a 3-year Longitudinal Study in Mainland China | Meiqi Xin

Slideset

HIV

Viral Hepatitis and Liver Disease

The Patterns of Primary Cotrimoxazole Prophylaxis in Adult HIV Patients in HIV Integrated Clinic Cipto Mangunkusumo Hospital Jakarta in 2004-2013 | Ken Ayu Mastini

Slideset

HIV

Viral Hepatitis and Liver Disease

TB Clinical Management Challenges | Nicholas Paton, MD, FRCP

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV surveillance – Are we missing out on key populations? | Yi-Chun Lo, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Integrating PrEP in prevention | Robert Grant, MD, MPH

Slideset

HIV

Viral Hepatitis and Liver Disease

Transmission networks among MSM | Shui-Shan Lee, MD, FRCP, FRCPA, FFPH

Slideset

HIV

Viral Hepatitis and Liver Disease

Long-term comorbidities | Saye Khoo, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Hyperlipidaemia and its association with CD4 recovery following antiretroviral therapy | Denise Chan

Slideset

HIV

Viral Hepatitis and Liver Disease

Clinical case presentation | Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP

Slideset

HIV

Viral Hepatitis and Liver Disease

Aspartate Aminotransferase to Platelet Ratio Index (APRI) is a Simple Test for Diagnosis Liver Cirrhosis in HIV Patients | Dr. K. Mariad

Slideset

HIV

Viral Hepatitis and Liver Disease

Metabolic Syndrome among Malaysian HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort | Sivaraj Naidu, MMedSc

Slideset

HIV

Viral Hepatitis and Liver Disease

Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1 | Dr. J. Rockstroh

Slideset

HIV

Viral Hepatitis and Liver Disease

Development of HIV Vaccine Candidates for Prevention and Treatment | Sandhya Vasan, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

APACC 2016

Sensitive Detection of Tenofovir-induced Tubular Injury with Urinary ß-2 Microglobuline in Vietnam | Daisuke Mizushima

Tenofovir-induced kidney tubular dysfunction in HIV-infected patients in Hong Kong | Denise Chan

Using the HVTN model to conduct HIV vaccine clinical trials | Xia Jin, MD, PhD

Safety and efficacy of tenofovir disoproxil fumarate plus emtricitabine for HIV pre-exposure prophylaxis in Thailand | Donn Colby, MD, MPH

Hepatitis C | Ching-lung Lai, MD, FRCP, FRACP

Hepatitis - HIV Co-infection | Jürgen Rockstroh, MD

Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD

Innovative Clinical Models | Nittaya Phanuphak, MD, PhD

Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD

Towards an HIV Cure; understanding the major barriers | Sharon Lewin, AO, FRACP, PhD, FAHMS

Transmitted drug resistance mutations among antiretroviral-naÏve adult patients in northern Vietnam | Vu Phuong Thao, PhD

The impact of NRTI resistance on the public health approach to PI-based second-line therapy in resource limited settings | Thuy Le, MD, DPhil

HIV Drug Resistance | Shinichi Oka, MD, PhD

Next Generation Sequencing for Detection of Drug Resistance Mutations in HIV-1 | Dr. Rakhmanaliev

They are not kids anymore: Standing at the crossroads of adolescent HIV Care | Annette Sohn, MD

Elimination of perinatal HIV: the Role of Safer Conception Strategies | Shannon Weber, MSW

Psychosocial Determinants of Anxiety and Depression among Children of HIV-infected Parents: a 3-year Longitudinal Study in Mainland China | Meiqi Xin

The Patterns of Primary Cotrimoxazole Prophylaxis in Adult HIV Patients in HIV Integrated Clinic Cipto Mangunkusumo Hospital Jakarta in 2004-2013 | Ken Ayu Mastini

TB Clinical Management Challenges | Nicholas Paton, MD, FRCP

HIV surveillance – Are we missing out on key populations? | Yi-Chun Lo, MD

Integrating PrEP in prevention | Robert Grant, MD, MPH

Transmission networks among MSM | Shui-Shan Lee, MD, FRCP, FRCPA, FFPH

Long-term comorbidities | Saye Khoo, MD, PhD

Hyperlipidaemia and its association with CD4 recovery following antiretroviral therapy | Denise Chan

Clinical case presentation | Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP

Aspartate Aminotransferase to Platelet Ratio Index (APRI) is a Simple Test for Diagnosis Liver Cirrhosis in HIV Patients | Dr. K. Mariad

Metabolic Syndrome among Malaysian HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort | Sivaraj Naidu, MMedSc

Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1 | Dr. J. Rockstroh

Development of HIV Vaccine Candidates for Prevention and Treatment | Sandhya Vasan, MD

Clinical case presentation | Mark Nelson, MD